Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8632199 | 1.00 | SRD5A2 (0.64) | SRD5A2SRD5A1 | |
| SCHEMBL8636570 | 0.95 | SRD5A2 (0.61) | SRD5A2SRD5A1 | |
| SCHEMBL8631960 | 0.90 | SRD5A2 (0.51) | SRD5A2SRD5A1 | |
| SCHEMBL8915261 | 0.88 | SRD5A2 (0.70) | SRD5A2SRD5A1 | |
| SCHEMBL8630348 | 0.88 | SRD5A2 (0.70) | SRD5A2SRD5A1 | |
| SCHEMBL8914653 | 0.88 | SRD5A2 (0.49) | SRD5A2SRD5A1 | |
| SCHEMBL9112620 | 0.86 | SRD5A2 (0.63) | SRD5A2SRD5A1 | |
| SCHEMBL8912851 | 0.86 | SRD5A2 (0.49) | SRD5A2SRD5A1 | |
| SCHEMBL9112554 | 0.86 | SRD5A2 (0.62) | SRD5A2SRD5A1 | |
| SCHEMBL8914630 | 0.85 | SRD5A2 (0.65) | SRD5A2SRD5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0567271-B1 | Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses | SANKYO CO (JP) | 1997-07-02 | — | — | EP | disclosed |
| EP-0725074-A2 | Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives | SANKYO COMPANY LIMITED (JP) | 1996-08-07 | — | — | EP | disclosed |
| US-5536714-A | Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-16 | — | — | US | disclosed |
| EP-0567271-A2 | Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses | SANKYO COMPANY LIMITED (JP) | 1993-10-27 | — | — | EP | disclosed |